Lumos Diagnostics Signs Exclusive Romania Distribution Agreement for Rapid Respiratory Infection Test; Shares Up 10%
MT Newswires Live
Jul 30
Lumos Diagnostics Holdings (ASX:LDX) has entered into an exclusive distribution agreement with Romania-based Alpha Medical to commercialize its FebriDx rapid point-of-care diagnostic test across Romania, according to a Thursday filing with the Australian bourse.
Alpha Medical has already placed an initial stocking order to ensure the products are available for immediate supply, per the filing.
The partnership expands the company's European distribution network, building on agreements with Henry Schein and Interlux to broaden access to FebriDx through experienced regional partners, the filing added.
The company's shares rose around 10% in recent Thursday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.